CD274 and non-small cell lung carcinoma: In this analysis, the reason for the longer OS in individuals with higher BMI may be the association of BMI with longer survival in individuals with NSCLC and high PD‐L1 expression levels who initially receive Pemb monotherapy, as previously described.